Stock Alert for Cardium Therapeutics Inc. Issued by MicroStockProfit

        Print
| Source: MicroStockProfit.com

DALLAS, April 30, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. (AMEX:CXM). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/ads/CXM

Cardium Therapeutics Inc. (CXM) focuses on the acquisition and development of biomedical product opportunities and businesses that have the potential to address unmet medical needs and definable pathways to partnering, commercialization and other monetizations. Its investment portfolio includes the Tissue Repair Company and Cardium Biologics, which are medical technology companies primarily focused on the development of therapeutic products for wound healing, bone repair and cardiovascular indications. In July 2009, the Company completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio.

Message Board Search for CXM: http://www.boardcentral.com/boards/CXM

In the report, the analyst notes:

"Consistent with its long-term strategy, CXM has stated that it intends to consider various corporate development transactions designed to place its product candidates into larger organizations or with partners having existing commercialization, sales and marketing resources, and a need for innovative products."

"In its report last month, CXM announced its agreement with bioRASI, an international contract research organization, to assist the Company in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures."

To read the entire report visit: www.microstockprofit.com/ads/CXM

See what investors are saying about CXM at penny stock forum

MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

MicroStockProfit.com
Brian Johnson
1-888-307-2850